Target intelligence / Profile preview

N-alpha-acetyltransferase 30, NatC catalytic subunit (NAA30)

Target
NAA30
Molecular classification
Enzyme, N-terminal acetyltransferase, GNAT family, N-terminal acetyltransferase C (NatC) complex
01

Overview

N-alpha-acetyltransferase 30 (NAA30) is the catalytic subunit of the NatC N-terminal acetyltransferase complex, an enzyme that co-translationally acetylates the N-termini of numerous eukaryotic proteins (especially those beginning with methionine followed by hydrophobic or amphipathic residues). NAA30’s activity stabilizes substrate proteins, protects them from degradation, and is required for correct mitochondrial function, organelle targeting, and cell viability. Loss or overexpression of NAA30 influences cancer cell growth and survival, and genetic variants are implicated in developmental syndromes and mitochondrial disease. NatC complexes are evolutionarily conserved and crucial for acetylating specific protein subsets across eukaryotes.

Other names
C14orf35MAK3NAT12FLJ35355Mak3pN-acetyltransferase 12N-acetyltransferase MAK3 homologNAT12PN-terminal acetyltransferase CNatC catalytic subunit
02

Mechanism of action

Inhibition of protein N-terminal acetylation, which has the potential to disrupt mitochondrial function, cell proliferation, and cancer cell viability by interfering with acetylation of substrate proteins, leading to increased protein degradation and altered organelle function.

03

Biological functions

Protein N-terminal acetylationProtein stabilizationMitochondrial integrity and functionOrganelle targetingCell proliferation and apoptosis regulation
04

Disease associations

CancerDevelopmental disordersMitochondrial disease and dysfunctionCellular developmental defects
05

Safety considerations

Cellular toxicity (depletion can induce mitochondrial dysfunction and apoptosis)Developmental consequences (loss of function is embryonic lethal in animal models)Potential off-target effects due to broad substrate profile
06

Biomarkers

Upregulation of NAA30 expressionTruncated isoforms of NAA30 (in thyroid cancer)Loss of mitochondrial membrane potentialAltered acetylation states of NatC substrates

Beyond the preview

Go deeper on N-alpha-acetyltransferase 30, NatC catalytic subunit (NAA30).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-alpha-acetyltransferase 30, NatC catalytic subunit (NAA30).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call